Production (Stage)
Tiziana Life Sciences Ltd
TLSA
$1.58
$0.2115.33%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 32.94% | 31.19% | 29.60% | 9.97% | -14.90% |
| Total Depreciation and Amortization | 29.17% | 15.23% | 1.98% | 30.92% | 88.24% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 209.43% | 82.69% | -8.45% | 356.32% | 212.05% |
| Change in Net Operating Assets | 65.11% | 177.49% | 216.73% | 165.10% | -35.91% |
| Cash from Operations | 90.28% | 84.39% | 79.54% | 49.36% | 19.97% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 0.10% | -99,900.00% | 25.29% | 62.63% |
| Cash from Investing | 98.10% | -3.20% | -101,300.00% | 24.77% | 62.63% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -18.49% | -38.39% | -64.13% | -83.67% | -116.36% |
| Issuance of Common Stock | 18,484.00% | 18,584.00% | -- | -- | -- |
| Repurchase of Common Stock | 79.53% | 94.90% | -- | 87.82% | 80.76% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 0.00% | -- | -- | -- |
| Cash from Financing | 2,190.61% | 516.62% | 101.05% | 90.86% | 84.51% |
| Foreign Exchange rate Adjustments | -1,210.71% | -79.22% | -14.17% | 34.01% | 92.96% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 115.00% | 92.07% | 72.59% | 49.09% | 29.61% |